Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Nutrition & Metabolism, 4 (1), 24
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue, first described by Raun and colleagues in 1998 as the first selective growth hormone secretagogue. It remains one of the most extensively characterised compounds of its class in the published research literature
Neuron 73 , 317332 (2012)
NAC might actually act as a pro-oxidant and might lower GSH and increase the amount of oxidized GSH
In osteosarcoma, a distinct subpopulation of CD36+ CAFs has been identified that internalizes oxidized low-density lipoprotein (OxLDL) and activates the PPARG-FABP4 metabolic axis, leading to secretion of ANGPTL4
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog, and Ipamorelin is a selective growth hormone secretagogue
